The phrase "as a starting point for development" is correct and usable in written English.
You can use it when discussing initial ideas, concepts, or frameworks that will be built upon in a project or process.
Example: "We can use this research as a starting point for development of our new product line."
Alternatives: "as a foundation for growth" or "as an initial basis for progress".
Our data recognized that compound 6p could be considered as a starting point for development of new JmjC inhibitors.
In creating ILSs, teachers are supported by scenarios and associated defaults ILSs that can be used as a starting point for development.
Supplementation of diagnostic criteria with biomarkers that are causally related to SCZ or endophenotypes may allow definition of homogeneous subgroups that are predictive of progression and therapeutic response in individual patients [20] and would serve as a starting point for development of therapeutics directed at causal variants.
The chemical structure of the furin inhibiting peptide could be used as a starting point for development of more novel and active peptidomimetics that target the intracellular furin cleavage step.
These discovered protein profiles may serve as a starting point for development of clinical blood tests to facilitate stratification and disease monitoring in dystrophinopathies, and the presented affinity-proteomics approach exemplifies a strategy toward the identification of blood-based protein biomarkers in rare diseases.
The framework presented here can serve as a starting point for the development of an evaluation framework for raw material accessibility at an early project development stage.
The validated model will be used as a starting point for process development.
Second, scenarios can be used in a formal way as a starting point for strategy development.
These compounds should prove useful for elucidating RGS-mediated activity and serve as a starting point for the development of a novel class of therapeutic agent.
A weakly immunogenic epitope of PrPC (YYR), which induces PrPSc-specific antibodies, is used as a starting point for vaccine development.
This serves as a starting point for the development of isoform-specific inhibitors that have potential cholesterol-reducing and antibiotic applications.
